Skip to content
Azatadine
Optimine, Trinalin (azatadine) is a small molecule pharmaceutical. Azatadine was first approved as Optimine on 1982-01-01. It is used to treat allergic rhinitis perennial, allergic rhinitis seasonal, ear diseases, respiration disorders, and urticaria in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Azatadine maleate
Tradename
Company
Number
Date
Products
OPTIMINEMerck Sharp & DohmeN-017601 DISCN1982-01-01
1 products
Hide discontinued
Azatadine maleate
+
Pseudoephedrine sulfate
Tradename
Company
Number
Date
Products
TRINALINMerck Sharp & DohmeN-018506 DISCN1982-03-23
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
allergic rhinitis perennialEFO_1001417D012221J30.89
allergic rhinitis seasonalEFO_0003956D006255J30
ear diseasesEFO_1001455D004427H93.9
respiration disorders—D012120J00-J99
urticariaEFO_0005531D014581L50
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
— R06: Antihistamines for systemic use
— R06A: Antihistamines for systemic use
— R06AX: Other antihistamines for systemic use in atc
— R06AX09: Azatadine
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAZATADINE
INNazatadine
Description
Azatadine is a benzo[5,6]cyclohepta[1,2-b]pyridine having a 1-methylpiperidin-4-ylidene group at the 11-position. It has a role as a H1-receptor antagonist and an anti-allergic agent. It is a benzocycloheptapyridine and a tertiary amine.
Classification
Small molecule
Drug classtricyclic histaminic-H1 receptor antagonists, loratadine derivatives (formerly-tadine)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1
Identifiers
PDB—
CAS-ID3964-81-6
RxCUI18600
ChEMBL IDCHEMBL946
ChEBI ID2946
PubChem CID19861
DrugBankDB00719
UNII ID94Z39NID6C (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 86 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
142,325 adverse events reported
View more details